Retatrutide 30mg

Retatrutide 30mg Vial by Peptide157 – Triple Agonist Peptide for Fat Loss, Metabolic Health & Glucose Regulation

Retatrutide 30mg by Peptide157 is a cutting-edge peptide that simultaneously activates GLP-1, GIP, and glucagon receptors — three key metabolic pathways governing appetite, blood sugar regulation, and energy expenditure. With its triple-receptor mechanism, Retatrutide provides a broader metabolic response than single-pathway peptides, making it highly valuable in advanced research settings.

The 30mg vial offers a mid-range option for researchers seeking flexibility in dosing protocols for studies on weight management, insulin sensitivity, appetite suppression, and overall metabolic optimization.